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Abstract
Introduction: During selective segregation of DNA, a cell asymmetrically divides and retains its template DNA.
Asymmetric division yields daughter cells whose genome reflects that of the parents, simultaneously protecting the
parental cell from genetic errors that may occur during DNA replication. We hypothesized that long-lived epithelial
cells are present in immortal, premalignant cell populations, undergo asymmetric division, retain their template
DNA strands, and cycle both during allometric growth and during pregnancy.
Methods: The glands of 3-week-old immune-competent Balb/C female mice were used intact or cleared of host
epithelium and implanted with ductal-limited, lobule-limited, or alveolar-ductal progenitor cells derived from
COMMA-D1 pre-malignant epithelial cells. 5-Bromo-2-deoxyuridine (5-BrdU) was administered to identify those cells
that retain their template DNA. Nulliparous mice were then either injected with [
3H]-thymidine (
3H-TdR) to
distinguish 5-BrdU label-retaining cells that enter the cell cycle and euthanized, or mated, injected with
3H-TdR,
and euthanized at various days after coitus. Sections were stained for estrogen receptor-a (ER-a) or progesterone
receptor (PR) with immunohistochemistry. Cells labeled with both 5-BrdU and
3H-TdR were indicative of label-
retaining epithelial cells (LRECs).
Results: Cells that retained a 5-BrdU label and cells labeled with [
3H]-thymidine were found in all mice and were
typically detected along the branching epithelium of mature mouse mammary glands. Cells containing double-
labeled nuclei (LRECs) were found in the intact mammary glands of both pregnant and nulliparous mice, and in
mammary glands implanted with premalignant cells. Double-labeled cells (
3H-TdR/5-BrdU) represent a small
portion of cells in the mammary gland that cycle and retain their template DNA (5-BrdU). Some label-retaining
cells were also ER-a or PR positive. LRECs distributed their second label (
3H-TdR) to daughter cells, and this effect
persisted during pregnancy. LRECs, and small focal hyperplasia, were found in all immortalized premalignant
mammary-implant groups.
Conclusions: The results indicate that a subpopulation of long-lived, label-retaining epithelial cells (LRECs) is
present in immortal premalignant cell populations. These LRECs persist during pregnancy, retain their original DNA,
and a small percentage express ER-a and PR. We speculate that LRECs in premalignant hyperplasia represent the
long-lived (memory) cells that maintain these populations indefinitely.
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In 1975, John Cairns proposed that, during the division of
stem/progenitor cells, the template DNA strand of a par-
ent cell is nonrandomly retained, whereas the newly
synthesized strand is selectively segregated to a daughter
cell [1]. As a result of this mechanism of asymmetric divi-
sion, any spontaneous mutations or errors that may
develop during DNA replication would occur in the newly
synthesized strand and be passed along to the daughter
cell, reducing the accumulation of genetic errors and, sub-
sequently, cancer risk of the long-lived parent cell. In addi-
tion, this type of scheme would allow the survival and
maintenance of progenitor “stem” cells that are capable of
producing expendable daughter cells. Since then, many
investigations have been carried out providing support for
Cairns “immortal DNA strand” hypothesis [2-4] that
include, among others, cells of the mammary gland and
intestine [5,6].
The mammary gland is a unique organ that matures in
the adult mammal by successive rounds of proliferation
and apoptosis [7,8]. To accomplish this feat, a subpopula-
tion of cells with regenerative properties is present in the
gland. It was postulated that if mammary “stem” cells
were present, these cells would retain an exogenously
applied label, being then identified as the “longer-lived”
cells of a population due to either mitotic quiescence or
selective DNA segregation [9]. Although the state of dif-
ferentiation was not clear (for example, pluripotent ver-
sus multipotent), it was evident that the mouse
mammary epithelium contained cells that were the pro-
genitors of the tissue [9]. It was found that some of these
mammary progenitor cells were capable of retaining their
label, and thus their template DNA strand, while they
traversed the cell cycle [6]. Newly synthesized DNA was
found to be distributed to daughter cells as a result of
asymmetric cell division [6].
To identify progenitor cells as well as to determine
whether asymmetric division occurs, two labels have
been applied to cells over the course of mammary gland
development [5,6,10]. In previous studies, 5-bromo-2-
deoxyuridine (5-BrdU) was administered during allo-
metric mammary gland growth and was used to identify
those long-lived cells that were capable of retaining their
label. A second DNA label, tritiated thymidine (
3H-TdR),
was used to distinguish those cells that were traversing
the cell cycle at various periods during this study. Cells
that contain a double-label of both 5-BrdU and
3H-TdR
in their nucleus were interpreted as long-lived, label-
retaining, cycling epithelial cells (LRECs).
Data have shown that various tissues within the body
use asymmetric division for cellular replacement, protec-
tion of long-lived cells from mutations that could occur
during DNA replication, and, consequently, from cancer
risk [5,6,11-13]. However, it is unknown whether pre-
cancer or cancer cells themselves use this method to
maintain their populations. Earlier work in our labora-
tory demonstrated that retroviral insertions were main-
tained undisturbed through several transplant
generations in nontransformed mammary populations
despite the presence of actively replicating retrovirus
and the presence of unintegrated retroviral DNA
[14,15]. This scenario was found in mouse mammary
tumor virus (MMTV)-induced epithelial hyperplastic
outgrowths, which are immortal (that is, capable of
unlimited growth during serial transplantation) [16].
Therefore, we hypothesized that long-lived epithelial
cells present in immortal cell populations undergo
asymmetric division, retain their template DNA strands,
and cycle both during allometric growth and during
pregnancy. We speculate that LRECs present in prema-
lignant hyperplasia represent long-lived cells that main-
tain these preneoplastic populations indefinitely.
Materials and methods
Mice
Three-week-old, immune-competent female Balb/C
mice were used as hosts for transplantation studies. All
mice were housed in Association for Assessment and
Accreditation of Laboratory Animal Care-accredited
facilities in accordance with the NIH Guide for the Care
and Use of Laboratory Animals.T h eN a t i o n a lC a n c e r
Institute Animal Care and Use Committee approved all
experimental procedures.
Cells
Clonal populations of immortalized, premalignant cells
were derived by using flow cytometry for side-popula-
tion (SP) cells from COMMA-D1 murine mammary
epithelial cells (Kittrell et al., unpublished data).
COMMA-D1 murine mammary epithelial cells were ori-
ginally isolated from the mammary glands of midpreg-
nant Balb/C mice [17]. Derived clonal populations
included “Non-Side Population 2” ("NSP2”), “Non-Side
Population 3” ("NSP3”), and “Side Population 3” ("SP3”).
The clonal population NSP2, interpreted to be a ductal
progenitor cell, yields a ductal outgrowth that fills the
mammary fat pad but does not differentiate in response
to hormones (Kittrell et al., unpublished data). NSP3
cells have poor growth in vivo and, when successfully
implanted, typically fill less than 10% of the mammary
fat pad with a nest of surviving cells (Kittrell et al.,
unpublished data). Finally, the population SP3 cells typi-
cally fills 20% to 59% of the mammary fat pad on injec-
tion (Kittrell et al., unpublished data). Cells were grown
in Dulbecco’s Minimal Essential Growth Medium
(Gibco, Carlsbad, CA) mixed with F12 Nutrient Medium
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Page 2 of 13(Gibco), supplemented with 2% fetal bovine serum
(Gibco), 1% 1 M HEPES Buffer (Sigma, St. Louis, MO),
1% 100× antibiotic antimycotic (Gibco), 5 ng/ml EGF
(per 500 ml; Sigma), and 10 μg/ml insulin (per 500 ml;
Sigma) at 37°C with 5% CO2.
Cell transplantation
Smith et al. [18-20] previously described in detail the
procedure used to clear the mammary epithelium from
the inguinal fat pad of 3-week-old host mice, as well as
the subsequent transplantation of cells. In brief, three
mice per condition (six control (thoracic) glands; six
inguinal fat pads) were anesthetized; both inguinal
mammary fat pads, cleared; and a cell suspension,
injected. Twenty thousand NSP2 cells, 50,000 NSP3
cells, or 50,000 SP3 cells suspended in phosphate-buf-
fered saline were inoculated in 10-μl volumes by using a
Hamilton (Reno, NV) syringe equipped with a 30-gauge
needle. Control mammary glands (thoracic) remained
intact.
Cell labeling in vivo
Two weeks after the implant surgery (mouse age of
5 weeks), 1 mg (100-μl volume), 5-bromo-2-deoxyuri-
dine (5-BrdU) was administered via intraperitoneal
injection for 2 consecutive days per week for 5 weeks
(Figure 1). The 5-BrdU injections were then stopped for
3 weeks (mouse age, 13 weeks), when some nulliparous
mice were inoculated with [
3H]-thymidine (
3H-TdR)
(50 μCi, 100 μl) and euthanized within 90 minutes (Fig-
ure 1). Remaining mice (mouse age, 12 to 13 weeks)
were mated with male Balb/C mice. Female mice were
subsequently inoculated with
3H-TdR (50 μCi, 100 μl)
and euthanized within 90 minutes at either 4 to 6, 8 to
10, or 12 to 15 days after coitus (Figure 1). Mammary
fat pads that were either intact (that is, control thoracic)
or containing the implanted cells were collected, fixed
in neutral buffered formalin, and prepared for autora-
diography and immunohistochemistry. Small intestine
from the same mice served as a non-mammary control
for autoradiography.
Immunohistochemistry
Mammary glands, embedded in paraffin, were cut in
5-μm sections and mounted on positively charged slides.
Sections were subsequently cleared in xylenes and rehy-
drated through a series of graded ethanols, and then
heated to a boil in a microwave in 10 mM citrate buffer
(BioGenex, San Ramon, CA) for antigen retrieval. Endo-
g e n o u sp e r o x i d a s ea c t i v i t yw a sb l o c k e db yu s i n ga0 . 6 %
hydrogen peroxide/methanol solution for 15 minutes at
room temperature. Slides were blocked with normal
goat serum (for estrogen receptor-a (ER-a) and proges-
terone receptor (PR) staining only) (Vector Laboratories,
Burlingame, CA) for 20 minutes at room temperature,
and then incubated overnight with either rabbit
Figure 1 Murine implantation experimental design. The inguinal mammary glands of 3-week-old Balb/C mice were cleared of host
epithelium and inoculated with either 20,000 (NSP2) or 50,000 (NSP3, SP3) immortalized, premalignant cells. Control (thoracic) number 3 and 8
glands remained intact. 5-BrdU was administered for 2 consecutive days/week for 5 weeks, followed by a break (chase) period of 3 weeks.
Nulliparous female mice were then inoculated with
3H-TdR and subsequently euthanized within 90 minutes. The remaining mice were mated,
inoculated with
3H-TdR, and euthanized within 90 minutes of receiving label at either 4 to 6, 8 to 10, or 12 to 15 days after coitus.
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Page 3 of 13polyclonal anti-human progesterone receptor (1:1,600;
Catalogue Number A0098; DAKO, Carpinteria, CA),
rabbit polyclonal anti-human estrogen receptor-a
(1:2,000; Catalogue Number sc-542; Santa Cruz, Santa
Cruz, CA), or biotinylated anti-mouse BrdU (1:50; Cata-
logue Number A21301MP; Invitrogen). Negative tissue
controls were included in all immunohistochemical ana-
lyses. For ER-a and PR staining, a secondary antibody of
goat anti-rabbit (1:100; Vector Laboratories) was applied
for 30 minutes at room temperature. Sections were then
processed for 30 minutes at room temperature with the
Vectastain ABC Standard Elite (Vector Laboratories),
and visualized by using diaminobenzidine (DAB; Sigma,
St. Louis, MO). Slides were counterstained with Gill’s
hematoxylin (Vector Laboratories).
Autoradiography
After immunohistochemical processing, slides were
transferred to distilled water and then coated with
Kodak NTB-2 liquid emulsion (Carestream Health, Inc.,
Rochester, NY) diluted 1:1 with distilled water. After
drying for 1 hour, slides were stored in lightproof slide
boxes at 4°C for 7 days. After exposure, the slides were
developed in Kodak D-19 (Carestream Health, Inc.,
Rochester, NY), washed in distilled water, and fixed in
Kodak rapid fixer diluted 1:1 with distilled water. Slides
were washed once more in distilled water and dehy-
drated through a series of graded ethanols and xylenes.
Sections were mounted with Permount (Fisher Scienti-
fic, Pittsburgh, PA), and slides subsequently observed
and evaluated for autoradiographic grains and for
immunostaining.
Cell labeling in vitro
Cells were plated in 25-mm
2 tissue flasks, cultured as
described earlier, and allowed to incubate overnight.
Cells were then treated with culture medium plus 0.5 μM
5-ethynyl-2-deoxyuridine (EdU) diluted in phosphate-
buffered saline (PBS) for imaging by using the Click-iT
EdU Imaging Kit (Invitrogen). Twenty-four hours later,
the EdU solution was removed, cells were washed with
PBS, and either the cells were immediately fixed at room
temperature for 15 minutes with 4% paraformaldehyde,
washed twice with Tris-buffered saline (TBS), and pro-
cessed for EdU imaging, or the culture medium was
replaced. Unfixed cells were then grown to confluence
and serially passaged 5 times (NSP2 and NSP3 cells seri-
ally passaged at 1:3; SP3 cells serially passaged at 1:6). At
the fifth passage, cells were washed with PBS and fixed
with 4% paraformaldehyde at room temperature. Fifteen
minutes later, the fixative was removed, and the cells
w e r ew a s h e dt w i c ew i t hT B S .F o rE d Ui m a g i n g ,c e l l s
were permeabilized for 20 minutes at room temperature
with 0.2% Triton X-100 and subsequently washed twice
with TBS. Freshly prepared Click-iT® reaction cocktail
(2 ml; Invitrogen, prepared as described by the manufac-
turer) per 25-mm
2 surface area was added to the cells,
which were then incubated in the dark for 30 minutes.
The reaction cocktail was subsequently removed, cells
were washed twice with TBS, and nuclei were stained for
4 minutes at room temperature with diamno-2-phenylin-
dole (1:1,000; DAPI; Invitrogen). DAPI was removed,
cells washed twice with TBS, and flask bottoms were
mounted by using Fluoromount-G (Southern Biotech,
Birmingham, AL). EdU-positive cells were visualized by
using fluorescence microscopy.
Results
Murine implantation experimental design
The mouse mammary gland is a dynamic organ that has
been shown to regenerate itself from as little as one cell
[14]. Consequently, it is likely that the mammary gland
contains stem or progenitor cells allowing self-renewal
to occur. Previously, it was shown that a population of
cells exists within the epithelium of the mouse mam-
mary gland that retains a
3H-TdR label, deemed label-
retaining cells [9]. With this knowledge, we sought to
identify and locate long-lived label-retaining mouse
mammary epithelial cells in vivo as well as to determine
the presence of long label retention in immortalized,
premalignant cell populations maintained in epithelium-
divested mammary fat pads. Three-week-old Balb/C
female mice were anesthetized, and their inguinal mam-
mary glands were cleared of host epithelium by using
protocols described by Smith et al. [18-20] (three mice
per condition; six cleared mammary fat pads). Either
20,000 or 50,000 immortalized, premalignant cells
(NSP2, 20,000 cells; NSP3 and SP3, 50,000 cells) were
inoculated in 10-μl volumes. Control (thoracic) glands
remained intact (three mice per condition; six intact
glands). Subsequently, to identify label-retaining cells
present in the mouse mammary gland, 5-BrdU was
administered to the 5-week-old female mice during allo-
metric mammary ductal growth for 2 consecutive days
per week for 5 weeks. The 5-BrdU injections were then
stopped for 3 weeks (mouse age, 13 weeks). Some of
the nulliparous female mice were then inoculated with
3H-TdR to distinguish 5-BrdU-label-retaining cells that
remain in the cell cycle, and subsequently euthanized.
The remaining 13-week-old mice were mated, inocu-
lated with
3H-TdR, and euthanized at either 4 to 6, 8 to
10, or 12 to 15 days after coitus (Figure 1). Glands were
collected and prepared for autoradiography and immu-
nohistochemistry. Sections were further stained for ER-
a or PR. Mammary cells within the ducts and alveoli
that retain both a 5-BrdU and
3H-TdR double-label are
indicative of long-lived label-retaining cycling epithelial
cells (LRECs).
Bussard et al. Breast Cancer Research 2010, 12:R86
http://breast-cancer-research.com/content/12/5/R86
Page 4 of 13Label-retaining cells were found in immortal cell
populations
Sections of mouse mammary fat pads implanted with
immortalized, premalignant cells were examined for evi-
dence of outgrowths containing label-retaining cells. Of
t h ei m p l a n t e df a tp a d s ,1 2o f1 6N S P 2 ,0o f1 8N S P 3 ,
and 10 of 18 SP3 yielded outgrowths that filled between
10% and 50% of the fat pad. In both pregnant and nulli-
parous mice, outgrowths containing NSP2-implanted
cells typically filled 10% to 40% of the fat pad, yielding
ductal structures with blunted side branches. Out-
growths containing SP3 cells filled 20% to 50% of the fat
pad with both ductal and lobular structures. Finally, of
specific note, NSP3 cells implanted into the mammary
fat pads of athymic nude mice yielded only focal areas
of epithelial cells. These results suggest that the NSP3
cells had indeed survived, but did not produce out-
growths consisting of ducts or alveoli or both, consistent
with those found with NSP2 or SP3 cell implants. These
spherical areas of epithelial cell growth typically filled
only 3% to 5% of the fat pad (thus, it was not recorded
as an outgrowth). In the NSP2 and SP3 outgrowths,
occasional areas of atypical epithelial hyperplasia (~0.1
to 1.5 mm in diameter), with nuclei that appeared to be
normal, were apparent (Table 1).
Among the outgrowths and intact glands, cells labeled
with 5-BrdU (long-lived label-retaining; template DNA
strand) or
3H-TdR (cell cycling; newly synthesized DNA
strand) were detected (Figure 2a-f: BrdU, green arrows;
3H-TdR, orange arrows). These single-labeled cells,
which included 0.1% to 23.8% labeled with 5-BrdU and
0.4% to 14.3% labeled with
3H-TdR, were typically
detected along the branching epithelium of mature
mouse mammary glands in both pregnant and nullipar-
ous mice (Table 2). Specifically, in the intact glands of
mice during early pregnancy (4 to 6 days after coitus),
we found that approximately 4.5% to 5.4% intralobular
epithelial cells were labeled with
3H-TdR (cell cycling;
newly synthesized DNA strand). At 8 to 10 days after
coitus, the number of intralobular epithelial cells labeled
with
3H-TdR decreased to 1.0% to 3.4% of the cells. By
12 to 15 days after coitus, alveolar differentiation was
substantial, with 5.0% to 7.5% intralobular epithelial
cells labeled with
3H-TdR. These results are consistent
with those described by Traurig [21], who found that
the highest rates of mammary epithelial cell proliferation
occurred on day 4 after coitus and day 12 (after the
onset of placental progestin secretion).
The frequency of epithelial cells labeled with
3H-TdR
in fat pads implanted with NSP2 cells (ductal progeni-
t o r )w a sm u c hl e s si np r e g n a n tm i c et h a ni nn o n p r e g -
nant (1.9% versus 14.3%, respectively; Table 2). These
values were in contrast to fat pads implanted with the
lobular progenitor cells NSP3 and SP3, in which the
numbers of
3H-labeled cells increased in response to
pregnancy. Cells containing double-labeled nuclei (both
stained with 5-BrdU and containing autoradiographic
grains (
3H-TdR; LREC)) were found within all intact
glands (Table 3) and were frequently located in mam-
mary outgrowths containing implanted premalignant
cells (Table 4). Representative images of double-labeled
cells are shown in the insets of Figure 2a-f, which were
similar for both nulliparous and pregnant mice whose
glands were either intact or fat pads were implanted
with immortalized premalignant cells.
Label-retaining cells found in immortal cell populations
asymmetrically divide
Asymmetric division (Figure 3) would be particularly
useful for stem and other long-lived cells, whereby a
cell’s archetype is retained for future generations. Being
specifically interested in whether this phenomenon
occurred within cells present in immortalized popula-
tions, we examined outgrowths from fat pads implanted
with premalignant cells and labeled with both 5-BrdU
and
3H-TdR. Asymmetric division with selective DNA
segregation was rare, but occurred in the NSP2, NSP3,
and SP3 cells that were implanted into cleared fat pads
in both nulliparous (Figure 4a) and pregnant (Figure 4b)
hosts. Furthermore, it was found that the number of
immortalized, premalignant cells that contain a single
label (either 5-BrdU or
3H-TdR) increased up to 108%
after chase, providing further support that label-retain-
ing cells within immortalized, premalignant populations
undergo asymmetric division and pass the newly synthe-
sized DNA strand to their daughters. A similar increase
was observed in the intact control glands after the chase
period.
Epithelial cells in intact and immortal cell populations
occasionally express ER-a or PR and take up
3H-TdR
It was next determined whether a percentage of epithe-
lial cells present in immortalized, premalignant cell
populations express estrogen receptor-a (ER-a)o rp r o -
gesterone receptor (PR). In the fat pads of nulliparous
mice implanted with immortalized, premalignant cells,
ER-a and PR expression was rare, being detected in 0 to
6% of immortalized cells counted per field of view
Table 1 Number of fat pads resulting in small focal
hyperplasia of pregnant or nulliparous mice implanted
with immortalized, premalignant cells
Cell type Nulliparous Pregnant
NSP2 6/6 6/10
NSP3 0/6 0/12
SP3 5/6 5/12
The number of fat pads containing small focal hyperplasia, versus those
without, was visualized by using a light microscope and enumerated.
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nulliparous mice, however, ER-a and PR expression was
found in considerably larger cell numbers than in
implanted fat pads: approximately 17% to 21% of cells
counted per field of view (Supplemental figure S1 in
Additional file 1; ER-a (a-c) and PR (d-f), red arrows)
(Tables 5 and 6). These data demonstrate that although
occasional cells express ER-a and PR, the number of
immortalized, premalignant cells that express the steroid
receptors is considerably smaller than the number found
in normal mammary epithelium.
During pregnancy, ER-a was expressed in approximately
6% to 7.5% of the cells counted per field of view in fat pads
with outgrowths of immortalized, premalignant cells
Figure 2 Immortal cell populations contain LRECs. Glands and fat pads from nulliparous mice either used intact or implanted with
immortalized, premalignant cell clones were labeled with 5-BrdU (green arrow) and
3H-TdR (orange arrow). Double-labeled cells (labeled with
both 5-BrdU and
3H-TdR, black arrow, inset) were identified by using light microscopy and were found in both intact glands (a, c, e) and
implanted fat pads (b, d, f). LRECs were found in all immortal, premalignant cells (b, NSP2; d, NSP3; f, SP3). Representative images are shown.
Scale bars equal 20 μm.
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immortalized, premalignant cells in pregnant mice was
substantially less than ER-a expression: 0% to 1% of cells
counted per field of view (Figure 5d; Table 6). In contrast,
5% to 7% of epithelial cells present within the intact glands
of pregnant mice expressed ER-a and PR (Supplemental
Figure 1) (Tables 5 and 6). Therefore, these data indicate
that immortalized, premalignant cells implanted into the
fat pads of pregnant mice that express PR are present in
small numbers.
Cells positive for ER-a ( F i g u r e5 aa n d5 c ;g r e e n
arrows, inset) or PR (Figure 5b and 5d; green arrows,
inset) and a
3H-TdR label were rare (<1%) both in out-
growths of immortalized, premalignant cells and in the
intact gland (Tables 7 and 8). Nevertheless, these results
suggest that some of the cells expressing the hormone
receptors were also progressing through the cell cycle.
Label-retaining cells were present in nonmammary
tissues
Although it is evident that label-retaining epithelial cells
are present in the regenerating mammary gland, it may
be possible that these cell populations are also present
in other tissues. Booth et al. [10] described that label-
retaining cells were found in several nonepithelial mam-
mary tissues, including nerve, fatty stroma, and
endothelial tissue. Consistent with that observation,
label-retaining cells, in this study, were also located
among cartilage (Supplemental figure S2a in Additional
file 2), adipose tissue (Supplemental figure S2b in Addi-
tional file 2), skeletal muscle (Supplemental figure S2c
in Additional file 2), and periductal cells (Supplemental
figure S2d in Additional file 1). These results indicate
that label-retaining cells are present in tissues in addi-
tion to the mammary epithelium.
Label-retaining cells were present in the premalignant
cell populations in vitro
To verify whether label-retaining cells were present in
immortalized, premalignant cell populations in vitro,
clones were cultured and treated with 0.5 μM EdU. EdU-
labeled cell nuclei were found in all immortalized, prema-
lignant cell populations in vitro at both passage 0 and pas-
sage 5. In passage 5 cell cultures, a twofold to 5.5-fold
decrease was found in the number of EdU-label retaining
cells present compared with passage 0 (Table 9; Figure 6).
One cause for the decrease in number of label-retaining
cells might be the result of dilution of noncycling cells
during serial passage. At passage 0, approximately 20% of
immortalized, premalignant cells are EdU positive. If dilu-
tion of noncycling cells were in play, then, after five pas-
sages, cells seeded at a 1:3 (NSP2, NSP3) or 1:6 dilution
(SP3) would have one cell in 243 (3
5) or one cell in 7,776
(6
5), respectively, as a label-retaining cell. This was not the
case, as five NSP2 cells of 34 cells (14.7%), seven NSP3
cells of 157 cells (4%), and 21 SP3 cells of 561 cells (3.8%)
were positive for EdU after five serial passages (Table 9).
Table 2 Percentage of cells expressing either a 5-BrdU or
3H-TdR single label per field of view found in the glands
and mammary fat pads of Balb/C female mice that were
either intact or implanted with immortalized,
premalignant cells
Percentage (%)
Nulliparous Pregnant
Intact (control) gland:Implant
group
5-BrdU
3H-
TdR
5-
BrdU
3H-
TdR
Intact:NSP
2 13.0:13.0 8.2:14.3 0.6:6.8 5.2:1.9
Intact:NSP
3 23.8:19.7 3.5:2.0 0.8:3.5 2.7:8.7
Intact:SP
3 12.0:4.4 4.8:0.4 0.1:4.0 1.9:6.5
The number of cells labeled with either 5-BrdU or
3H-TdR was counted in
three random fields of view (400× magnification). In addition, the total
number of cells in three random fields of view was determined (>1000 cells
total counted; 400× magnification). The total number of cells labeled with
either 5-BrdU or
3H-TdR was then divided by the total number of cells in a
field of view, and the percentage of cells labeled with either 5-BrdU or
3H-TdR
per field of view was obtained.
Table 3 Percentage of double-labeled cells per field of
view found in the intact glands of nulliparous or
pregnant Balb/C female mice
Percentage (%)
Intact gland group Nulliparous Pregnant
Intact Group 1 0.02 0.04
Intact Group 2 0.3 0.004
Intact Group 3 0.1 0.02
The number of double-labeled (5-BrdU and
3H-TdR) cells was counted in three
random fields of view (400× magnification). Next, the total number of cells in
three random fields of view was determined (>1000 cells total counted; 400×
magnification). The total number of double-labeled cells was divided by the
total number of cells, and the percentage of double-labeled cells per field of
view was obtained. The label “intact group” corresponds to the unoperated
on (control) number 3 and 8 axillary mammary glands in each experimental
group.
Table 4 Percentage of double-labeled cells per field of
view found in the mammary fat pads of nulliparous or
pregnant Balb/C female mice implanted with
immortalized, premalignant cells
Percentage (%)
Cell-type group Nulliparous Pregnant
NSP2 0.15 0
NSP3 0.2 0.03
SP3 0 0.01
The number of double-labeled (5-BrdU and
3H-TdR) cells was counted in three
random fields of view (400× magnification). Next, the total number of cells in
three random fields of view was determined (>1000 cells total counted; 400×
magnification). The total number of double-labeled cells was divided by the
total number of cells, and the percentage of double-labeled cells per field of
view was obtained.
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Page 7 of 13These results show that the label-retaining, premalignant
populations are selectively preserved throughout serial
passage in vitro. These data imply that label-retaining, pre-
malignant cells were not out of the cell cycle during pas-
sage, but nevertheless retained their original DNA label. In
addition, label-retaining cells in the fifth passage were
occasionally found juxtaposed to unlabeled cells suggest-
ing selective label retention during mitosis (Figure 6).
Discussion
Our data demonstrate that a subpopulation (<1%) of long-
lived cells (LRECs), both in immortalized, premalignant
Figure 3 Diagram of symmetric and asymmetric division. Brown background indicates a cell with template DNA; black dots indicate a cell
that is cycling. (a) During symmetric division, a cycling (black dots) parent cell with template DNA (brown background) divides equally, yielding
two proliferating (black dots) identical daughter cells that each have one template DNA strand (brown background) and one newly synthesized
DNA strand. (b) In asymmetric division, a cycling (black dots) parent (stem) cell with template DNA (brown background) undergoes unequal
division, retaining its template DNA (brown background), but yielding one proliferating (black dots) daughter cell containing DNA that was
newly synthesized from the parent’s template strand.
Figure 4 Asymmetric cell division occurred in immortalized, premalignant cell populations. Fat pads from mice implanted with immortalized,
premalignant cells were labeled with 5-BrdU and
3H-TdR. Double-labeled cells that undergo asymmetric division and pass a
3H-TdR label on to their
daughter cell (red arrow) in (a) nulliparous and (b) pregnant mice were identified by using light microscopy. Scale bars equal 5 μm.
Bussard et al. Breast Cancer Research 2010, 12:R86
http://breast-cancer-research.com/content/12/5/R86
Page 8 of 13Figure 5 LRECs present in the mammary fat pads of pregnant and nulliparous mice implanted with immortalized, premalignant cell
populations express ER-a and PR and incorporate
3H-TdR into their nuclei. Immunohistochemistry for ER-a ((a, c), red arrow) and PR ((b,
d), red arrow), and labeling for
3H-TdR, was performed on mouse mammary glands (inguinal) of nulliparous mice (a, b) or pregnant (c, d)
implanted with immortalized, premalignant cells.
3H-TdR was incorporated into the nucleus of some cells expressing the steroid receptors (green
arrow, inset). Representative images are shown. Scale bars equal 20 μm.
Table 5 Percentage of cells expressing ER-a per field of
view found in the glands and mammary fat pads of Balb/
C female mice that were either intact or implanted with
immortalized, premalignant cells
Percent (%)
Intact (control) gland:Implant group Nulliparous Pregnant
Intact:NSP2 20.4:5.8 7.5:7.5
Intact:NSP3 21.5:6.1 7.4:5.9
Intact:SP3 16.4:2.3 6.8:6.4
The number of cells expressing ER-a was counted in three random fields of
view (400× magnification). In addition, the total number of cells in three
random fields of view was determined (>1000 cells total counted; 400×
magnification). The total number of cells expressing ER-a was then divided by
the total number of cells in a field of view, and the percentage of cells
expressing ER-a per field of view was obtained.
Table 6 Percentage of cells expressing PR per field of
view found in the glands and mammary fat pads of Balb/
C female mice that were either intact or implanted with
immortalized, premalignant cells
Percentage (%)
Intact (control) gland:Implant group Nulliparous Pregnant
Intact:NSP2 21.0:5.2 5.2:1.0
Intact:NSP3 18.2:0.6 5.8:0.0
Intact:SP3 17.8:0.0 6.8:0.8
The number of cells expressing PR was counted in three random fields of
view (400× magnification). In addition, the total number of cells in three
random fields of view was determined (>1000 cells total counted; 400×
magnification). The total number of cells expressing PR was then divided by
the number of cells in a field of view, and the percentage of cells expressing
PR per field of view was obtained.
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Page 9 of 13cells and in the normal mouse mammary gland, maintain
and protect template DNA through selective strand segre-
gation during cell division. During pregnancy, the LRECs
are stimulated to enter the cell cycle and contribute to
new progeny through asymmetric divisions. We postulate
that these cells represent long-lived cells (LRECs) are the
source of regenerative capacity for both normal and pre-
malignant epithelial populations. In a sense, this subpopu-
lation of long-lived cells represents the “memory” or
“repository” cells of these populations.
Here, we show that both untransformed mammary
epithelial cells and immortalized, premalignant epithelial
cells divide asymmetrically (Figure 4) and are selectively
conserved through serial passage in vitro (Figure 6), sug-
gesting that a subpopulation of progenitor-like cells
resides in each of these populations. Is it the case that
these label-retaining epithelial cells may be pluripotent
or multipotent stem cells, giving rise to progeny com-
mitted to a specific lineage? Although the answer to
that question is presently unknown, in this study, it was
shown that LRECs are capable of self-renewal, a
characteristic specific to stem cells, as identified by
retention of a 5-BrdU label. Cells in the small intestine,
neural tissue, skeletal muscle, and Drosophila ovarioles,
as well as the mammary gland, have been shown to
retain their template DNA selectively during asymmetric
divisions [6,10,22]. In these cases, all of the chromatids
possessing template DNA are retained. What is the
mechanism(s) by which this is accomplished? Several
reports have indicated possible mechanisms by which
older DNA chromatids may be recognized and selec-
tively retained. In fission, yeast kinetochore-specfic pro-
teins associate selectively with the older chromatids
during meiotic divisions [23]. In mouse colon crypt
epithelial cells, sister chromatids were nonrandomly seg-
regated during mitotic divisions, apparently by recogni-
tion of specific DNA sequences [24]. In addition,
Armakolas et al. [25] suggest that individual old and
new DNA strands may be selectively distributed during
mitotic division in differentiating cells of different
lineages. For example, selective strand segregation was
found in endodermal cells, whereas random strand seg-
regation was noted in others [25]. Thus, it may be possi-
ble that the cell type or tissue microenvironment or
both regulate the mode of strand distribution, and
therefore the pattern of cellular differentiation.
In addition to the mammary epithelium, label-retain-
ing cells were also found in nonepithelial mammary
structures. Booth et al. [10] discovered label-retaining
cells in nerve, fatty stroma, and endothelial tissue. Here,
label-retaining cells were also found within cartilage,
adipose tissue, skeletal muscle, and in periductal cells
(Supplemental Figure S2a-d in Additional file 2). These
results suggest that progenitor cells may be present else-
where within the body, serving as tissue reserve cells
and being used only when needed. An example of such
a cell can be found in skeletal muscle [13,26]. Shinin
et al. [13] identified a subpopulation of muscle satellite
cells that divided asymmetrically and retained their tem-
plate DNA during muscle regeneration. It was found
that these effects persisted during muscle growth, as
well as during muscle injury [13]. At the present,
Table 7 Percentage of cells expressing an ER-a and
3H-
TdR double-label per field of view found in the glands
and mammary fat pads of Balb/C female mice that were
either intact or implanted with immortalized,
premalignant cells
Percentage (%)
Intact (control) gland:Implant group Nulliparous Pregnant
Intact:NSP2 0.20:0.10 0.13:0.01
Intact:NSP3 0.04:0.05 0.08:0.03
Intact:SP3 0:0.09 0.06:0.06
The number of cells expressing an ER-a and
3H-TdR double-label was counted
in three random fields of view (400× magnification). In addition, the total
number of cells in three random fields of view was determined (>1000 cells
total counted; 400× magnification). The total number of cells expressing an
ER-a and
3H-TdR double-label were then divided by the total number of cells
in a field of view, and the percentage of cells expressing an ER-a and
3H-TdR
double-label per field of view was obtained.
Table 8 Percentage of cells expressing a PR and
3H-TdR
double-label per field of view found in the glands and
mammary fat pads of Balb/C female mice that were
either intact or implanted with immortalized,
premalignant cells
Percentage (%)
Intact (control) gland:Implant group Nulliparous Pregnant
Intact:NSP2 0.20:0.02 0.04:0.006
Intact:NSP3 0.0:0.05 0.17:0.0
Intact:SP3 0.10:0.0 0.07:0.02
The number of cells expressing a PR and
3H-TdR (double-label) were counted
in three random fields of view (400× magnification). In addition, the total
number of cells in three random fields of view was determined (>1000 cells
total counted; 400× magnification). The total number of cells expressing a PR
and
3H-TdR double-label was then divided by the total number of cells in a
field of view, and the percentage of cells expressing a PR and
3H-TdR double-
label per field of view was obtained.
Table 9 Percentage of label-retaining cells in vitro
Percentage of cells expressing EdU
Cell type Passage 0 Passage 5
NSP2 17.4 14.7
NSP3 23.2 4.0
SP3 21.0 3.8
The number of cells expressing EdU was counted in three random fields of
view (100× magnification). In addition, the total number of cells in three
random fields of view was determined (>100 cells total counted; 100×
magnification). The total number of cells expressing EdU was then divided by
the total number of cells in a field of view, and the percentage of cells
expressing EdU per field of view was obtained.
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Page 10 of 13though, it is unknown whether a specific physiological
event, such as wounding, pregnancy, or cell death, is
necessary to trigger the activation of tissue-specific pro-
genitor cells. Nevertheless, their presence in the tissues
identified in this study is intriguing.
Cells expressing either ER-a or PR also incorporated
3H-TdR into their nuclei (Tables 7 and 8), indicating that
some steroid receptor-positive cells are traversing the cell
cycle. These results are consistent with those found by
Booth et al. [10], who surmised that the epithelial cells
that express either ER-a or PR and incorporate
3H-TdR
into their nuclei represent a functionally distinct cell
population undergoing asymmetric division [10]. Thus,
these results suggest that within the mammary gland,
Figure 6 Label-retaining cells were present in immortalized, premalignant cells in vitro. Immortalized, premalignant cell populations NSP2
(a, b), NSP3 (c, d), and SP3 (e, f) were cultured in vitro as described in Materials and methods. Cells were plated, allowed to incubate overnight,
treated with 0.5 μM EdU for 24 hours, and fixed, permeabilized, labeled with Alexa Fluor® 488, and counterstained with DAPI either (a, c, e)
immediately or (b, d, f) after serial passage. Representative images are shown. Scale bars equal 40 μm.
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Page 11 of 13distinct cell populations exist (for example, ER-a and/or
PR positive versus ER-a and/or PR negative), each poten-
tially arising from a different progenitor.
Data presented in this study indicate that only a small
number (<1%) of cells present in hyperplasia possess
these progenitor-like cell characteristics. We believe it is
possible that the lower frequency of double-labeled cells
recorded in the present experiments may be due to the
relatively short pulse used to introduce the second DNA
label into the tissue, especially if cycling LRECs pass
more slowly through the S phase than do symmetrically
dividing cells. In past experiments [6], the second label
was applied over a 48-hour period (in the presence of
estradiol, estradiol plus progesterone, or estradiol, pro-
gesterone, plus prolactin), yielding a population of
nearly 2% double-labeled cells [6]. Labeling for more
than 48 hours may likely result in labeling both slowly
cycling and rapidly cycling cells. Alternatively, it may be
the case that immortalized, premalignant populations
already contain progenitor cells whose template DNA
strand was not initially labeled by 5-BrdU. In this case,
the unlabeled template strand would be selectively
retained, and the newly synthesized strand, labeled with
5-BrdU, would be passed to a daughter cell through
a s y m m e t r i cd i v i s i o n .T h u s ,t h en u m b e ro fL R E C s
(tagged by 5-BrdU) would be small. In the data pre-
sented here, however, we suppose that symmetric
expansion of the progenitor population occurs, render-
ing this supposition unlikely.
Conclusions
These findings demonstrate that a subpopulation of
long-lived cells, characterized by their ability to retain a
DNA label, are present in immortalized, premalignant
cells. These cells retain their original DNA strands and
divide asymmetrically to maintain their cell populations
and protect their template DNA. During pregnancy,
where these cells persist, they are stimulated to enter
the cell cycle and contribute to new progeny through
asymmetric divisions. New long-lived label-retaining
cells, which include those that express ER-a and PR,
continue to cycle. We speculate that LRECs present in
premalignant hyperplasia represent the long-lived (mem-
ory) cells that maintain these populations indefinitely.
Additional material
Additional file 1: Supplemental figure S1. LRECs express ER-a and PR
and incorporate
3H-TdR into their nuclei. Immunohistochemistry for ER-a
and PR, as well as labeling for
3H-TdR, was performed on the intact
mammary glands (thoracic) of female mice. Epithelial cells present in the
glands expressed ER-a (A-C, red arrow) as well as PR (D-F, red arrow) in
the NSP2 (A, D), NSP3 (B, E), and SP3 (C, F) groups.
3H-TdR was
incorporated into the nucleus of some cells expressing the steroid
receptors (green arrow, inset). Scale bars equal 20 μm.
Additional file 2: Supplemental figure S2. Label-retaining cells are
present in nonmammary tissues. Cells expressing 5-bromo-2-
deoxyuridine were found in (a) cartilage, (b) adipose tissue, (c) skeletal
muscle, and (d) periductal cells. Scale bars equal 20 μm.
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